Press release
Rise In Prevalence Of Methicillin-Resistant Staphylococcus Aureus Infections: Powering Innovation and Expansion in the Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market by 2025
Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs
What Is the Expected CAGR for the Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Through 2025?
In recent times, the market size of drugs for methicillin-resistant staphylococcus aureus (MRSA) has seen continuous growth. The market, which was worth $2.35 billion in 2024, is projected to expand to $2.47 billion in 2025, representing a compound annual growth rate (CAGR) of 4.9%. The surge in the historic period is a result of concerns over antibiotic resistance, infections contracted in hospitals, surgical procedures, a worldwide rise in MRSA cases, and high rates of mortality.
What's the Projected Size of the Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market by 2029?
The market size of the methicillin-resistant staphylococcus aureus (MRSA) drugs market is anticipated to witness robust growth in the forthcoming years. The market is projected to reach "$3.09 billion by 2029, expanding at a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this growth during the forecast period include the ongoing challenge of antibiotic resistance, advancements in the diagnosis of MRSA, worldwide healthcare-associated infections, surgical preventative measures, and an increase in MRSA cases acquired in the community. The forecast period will also observe several key trends such as the investigation of immunomodulators, strategic collaborations for drug innovation, therapies tailored to strain attributes, a focus on pediatric-specific formulae, and global health programs fighting against antibiotic resistance.
View the full report here:
https://www.thebusinessresearchcompany.com/report/methicillin-resistant-staphylococcus-aureus-mrsa-drugs-global-market-report
Top Growth Drivers in the Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Industry: What's Accelerating the Market?
The expansion of the methicillin-resistant Staphylococcus aureus drugs market is likely to be propelled by the escalating occurrence of Hospital Acquired Infections (HAIs). These infections are contracted by patients during their stay in a healthcare facility, typically appearing 48 hours or beyond post-admission. Factors such as unsterilized medical equipment, inadequate hand cleanliness protocol among healthcare workers, excessive use of antibiotics, extended hospitalization, and patients' compromised immune system contribute to HAIs. Drugs designed for methicillin-resistant Staphylococcus aureus (MRSA) prove effective in combating HAIs by targeting and eliminating MRSA strains that defy standard antibiotics, consequently toning down the intensity and transmission of such infections within healthcare confines. For instance, the World Health Organization, a Switzerland-based Intergovernmental organization, reported in 2023 that 136 million instances of healthcare-associated antibiotic-resistant infections occur globally every year. Hence, the surge in incidences of methicillin-resistant Staphylococcus aureus infections stimulates the growth of the methicillin-resistant Staphylococcus aureus drugs market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10859&type=smp
What Trends Will Shape the Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Through 2029 and Beyond?
Product innovation is gaining traction in the Methicillin-Resistant Staphylococcus aureus (MRSA) drug market. In March 2023, US-based Endo launched the first generic version of Pylera capsules for treating Helicobacter pylori infections, improving access to effective gastric ulcer therapy while reducing treatment costs.
What Are the Main Segments in the Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market?
The methicillin-resistant staphylococcus aureus (MRSA) drugs market covered in this report is segmented -
1) By Drug Class: Lipopeptides, Oxazolidinones, Cephalosporin, Tetracycline, Folate Antagonist, Lipoglycopeptide, Other Drug Classes
2) By Indication: Skin Infections, Bone and Joint Infections, Bacteremia, Animal Infections
3) By MRSA Type: Hospital-Acquired (HA-MRSA), Community-Acquired (CA-MRSA)
4) By Route of Administration: Oral Administration, Parenteral Administration
5) By End User: Hospitals and Clinics, Research and Academic Institutes, Other End-Users
Subsegments:
1) By Lipopeptides: Daptomycin
2) By Oxazolidinones: Linezolid, Tedizolid
3) By Cephalosporin: Ceftaroline
4) By Tetracycline: Minocycline, Doxycycline
5) By Folate Antagonist: Trimethoprim Or Sulfamethoxazole
6) By Lipoglycopeptide: Telavancin, Dalbavancin, Oritavancin
7) By Other Drug Classes: Vancomycin, Clindamycin, Quinupristin Or Dalfopristin
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10859&type=smp
Which Top Companies are Driving Growth in the Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market?
Major companies operating in the methicillin-resistant staphylococcus aureus (MRSA) drugs market include Basilea Pharmaceutica Ltd., Merck & Co Inc., Pfizer Inc., Theravance Biopharma Inc., Allergan plc, Cumberland Pharmaceuticals Inc., Debiopharm International S.A., AbbVie Inc., Innovation Pharmaceuticals Inc., Melinta Therapeutics Inc., Nabriva Therapeutics plc, Paratek Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., AmpliPhi Biosciences Corporation, AstraZeneca plc, Meiji Seika Kaisha Ltd., GlaxoSmithKline plc, Johnson & Johnson, Sanofi S.A., Novartis, Wockhardt, Sun Pharmaceutical Industries Ltd., Lupin Limited, Glenmark Pharmaceuticals, Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Astellas Pharma Inc.
Which Regions Will Dominate the Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Through 2029?
North America was the largest region in the global methicillin-resistant staphylococcus aureus drugs market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the methicillin-resistant staphylococcus aureus (MRSA) drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10859
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rise In Prevalence Of Methicillin-Resistant Staphylococcus Aureus Infections: Powering Innovation and Expansion in the Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market by 2025 here
News-ID: 4095587 • Views: …
More Releases from The Business Research Company
Emerging Trends to Reshape the Xenotransplantation Market: Xvivo's Innovative Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Xenotransplantation Market Size By 2025?
The market size of xenotransplantation has seen robust expansion in the past few years. The market value is projected to increase from $14.68 billion in 2024 to $15.82 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.8%.…
Wood Based Panel Market Landscape to 2034: Key Forces Shaping the Next Decade of …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Wood Based Panel Market Through 2025?
In recent times, the market size of wood-based panels has seen considerable growth. The market which was valued at $176.85 billion in 2024 is projected to rise to $190.52 billion in 2025, showing a compound annual…
Soaring Demand Set to Propel Wireless Speakers Market to $111.25 Billion by 2029
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Wireless Speakers Market Size Growth Forecast: What to Expect by 2025?
In recent times, the wireless speakers market has experienced substantial expansion. The market size is expected to increase from $37.14 billion in 2024 to $45.71 billion in 2025, growing at a compound annual growth rate (CAGR) of 23.1%.…
Wind Turbine Casting Market Landscape 2025: Forecast Data and Growth Strategy In …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Wind Turbine Casting Industry Market Size Be by 2025?
The market size for wind turbine castings has seen solid growth in the past few years. Its value is projected to increase from $2.31 billion in 2024 to $2.46 billion in 2025, with a compound annual growth…
More Releases for MRSA
Mrsa Drugs Market Size, Share, Forecast Report 2025-2034
The MRSA Drugs Market Is Set To Grow At An Estimated CAGR Of 6.5% From 2025 To 2034, Rising From $6.8 Billion In 2024 To $11 Billion By 2034.
On April 29, 2025, Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Mrsa Drugs market goods. The market study excludes key regions that are accelerating marketization. This section…
Combating MRSA with Cutting-Edge Pharmaceutical Advances
"The Business Research Company recently released a comprehensive report on the Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The methicillin-resistant…
MRSA Antibiotics Market Analysis, Size, Current Scenario and Future Prospects
MRSA Antibiotics Market was estimated at US$ billion in 2023 and is predicted to reach US$ billion by 2029 with sales revenue expected to register CAGR of 4.3% over the forecast period. Rising number of surgical conditions from chronic diseases such as diabetes, chronic respiratory and renal diseases are expected to increase the demand of post-operative MRSA anti-infective therapies.
Important changes in the business allow key players to attain larger profits.…
VRE and MRSA Antibiotic Market 2021 | Detailed Report
According to Market Study Report, VRE and MRSA Antibiotic Market provides a comprehensive analysis of the VRE and MRSA Antibiotic Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of VRE and MRSA Antibiotic Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4645656
The…
MRSA Testing Market Analysis of Top industry Scenario
Global MRSA Testing Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).
According to a new report published by Allied Market Research, titled, "Global MRSA Testing Market by Type (Immunodiagnostics and Molecular Diagnostics) By…
Find out Why MRSA Antibiotics Market Is Thriving Worldwide
A new market study on Global (United States, European Union and China) MRSA Antibiotics Market with 100+ market data Tables, Pie Chart & Graphs is released that will provide complete assessment of the Market and covers evolving trends, current scenario analysis and growth factors, and industry validated market data. The research study provides market breakdown by revenue and volume (if applicable) and price history estimates for Global (United States, European…
